M. Thalheimer

Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study

Hannes Wandt, Kerstin Schaefer‐Eckart, Knut Wendelin et al. · The Lancet · 2012 · 339 citations

Medicine, Hematology, Oncology +13

Aprepitant, Granisetron, and Dexamethasone for Prevention of Chemotherapy-Induced Nausea and Vomiting After High-Dose Melphalan in Autologous Transplantation for Multiple Myeloma: Results of a Randomized, Placebo-Controlled Phase III Trial

Thomas Schmitt, Hartmut Goldschmidt, Kai Neben et al. · Journal of Clinical Oncology · 2014 · 94 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Association of preventable adverse drug events with inpatients' length of stay-A propensity-matched cohort study

Stefanie Amelung, Andreas D. Meid, Michael Nafe et al. · International Journal of Clinical Practice · 2017 · 34 citations · Full text

Pharmacy, Internal Medicine, Clinical Epidemiology +12

Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitals

C. Rieger, Oliver A. Cornely, Torsten Hoppe‐Tichy et al. · Mycoses · 2012 · 23 citations

Medicine, Hematology, Pharmacoeconomics +17

A Therapeutic Platelet Transfusion Strategy without Routine Prophylactic Transfusion Is Feasible and Safe and Reduces Platelet Transfusion Numbers Significantly: Preliminary Analysis of a Randomized Study in Patients after High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation

Hannes Wandt, Knut Wendelin, Kerstin Schaefer‐Eckart et al. · Blood · 2008 · 16 citations

Medicine, Hematology, Chemotherapy +15